Intellipharmaceutics International Inc. (IPCI)

[cysonic]

According to the filing as of October 25, 2018 both Odidis own each 578,131 shares. The Odidi Holdings Inc. holds also 578,131 shares.

So in sum 1,734,393 shares.

The filing says "On October 25, 2018, there were 8,107,243 Common Shares outstanding (post-reverse split)."

So the Odidis and their Holding have together 21,3% of the company.

The rest is, as you correctly noted, "only" beneficial owning (options and Convertible Debenture).


"The reverse split will reduce the number of outstanding common shares from approximately 43.5 million to approximately 4.35 million."
https://www.intellipharmaceutics.com/news-media/press-releases/detail/176/intellipharmaceutics-announces-one-for-10-reverse-stock (September 13, 2018)

-> As there were 8,107,243 Common Shares outstanding as of October 25, 2018, there must have been 3,75 million warrants exercised already imho.


So my point still is that the Odidis still have a huge interest that the company suceeds and that we can expect news soon (~ 4 weeks). If the stock really gets delisted from the Nasdaq, that will be the end of the story.